IL2 and systemic lupus erythematosus: In addition, low dose of IL-2 can increase the number of Treg cells and maintain immune homeostasis transiently to alleviate disease symptoms in SLE patients [9–13], however, majority of the studies are focused on the short-term effect [13] which is not a feasible long term solution [14].